Form 8-K - Current report:
SEC Accession No. 0001104659-22-128270
Filing Date
2022-12-19
Accepted
2022-12-19 16:38:39
Documents
14
Period of Report
2022-12-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2233021d1_8k.htm   iXBRL 8-K 27006
2 EXHIBIT 99.1 tm2233021d1_ex99-1.htm EX-99.1 9989
6 GRAPHIC tm2233021d1_ex99-1img001.jpg GRAPHIC 4242
  Complete submission text file 0001104659-22-128270.txt   220764

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA trda-20221219.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE trda-20221219_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trda-20221219_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2233021d1_8k_htm.xml XML 3595
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40969 | Film No.: 221471594
SIC: 2834 Pharmaceutical Preparations